Newsfiscal.ai
iSpecimen Expands Into AI-Powered Drug Discovery and Disease Trend Monitoring With Acquisition of Foldlab AI Products
· Published
Article summary
iSpecimen Inc. has completed the acquisition of two artificial intelligence products from Foldlab AI Ltd. to enter the AI-powered disease intelligence market.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…